4127.TWO · TLB
Taiwan · RS rating 29 · As of 2026-10-08
| Price | 40.55 TWD |
|---|---|
| 1-day change | -5.5% |
| RS rating (overall / 1M / 3M / 12M) | 29 / 1 / 1 / 69 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 34 / 27 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -58.7% |
| Sales growth Q/Q | -6.8% |
| Distance from 52-week high | +56.1% |
| Market cap (USD) | $65.3M |